Form 4: Kodiak Sciences CFO Executes Stock Option and Sale

Kodiak Sciences CFO John A. Borgeson exercised 30,000 stock options and subsequently sold the shares under a 10b5-1 trading plan.

Summary

• CFO John A. Borgeson exercised 30,000 stock options at an exercise price of $1.04 per share.
• Following the exercise, the reporting person sold a total of 30,000 shares of common stock.
• The sales were executed in two tranches: 25,896 shares at a weighted-average price of $34.01 and 4,104 shares at a weighted-average price of $34.67.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and represents standard executive equity management.

Positives

• The transaction demonstrates the exercise of vested equity compensation, reflecting long-term incentive alignment.
• The sale was conducted via a pre-arranged 10b5-1 plan, which typically mitigates concerns regarding insider trading based on non-public information.

Negatives

• The transaction results in a reduction of the CFO's direct beneficial ownership of company stock.

Risks

• Market volatility may impact the value of remaining holdings.
• Reliance on 10b5-1 plans does not eliminate the inherent risk of negative market perception regarding insider selling.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is standard practice for executives in the biotechnology sector to manage personal liquidity and diversify portfolios, and is generally viewed as neutral by the market.

Comparison to Industry Standards

• The use of 10b5-1 plans is a standard governance practice for C-suite executives in publicly traded biotech firms to ensure compliance with SEC regulations.
• The exercise of options near their expiration date is a common financial management strategy for executives.

Stakeholder Impact

• Minimal impact on shareholders as the sale was conducted through a pre-established trading plan.

Key Dates

Keywords

Kodiak Sciences, KOD, Insider Trading, Form 4, CFO, Stock Options, 10b5-1